Qishi Biotechnology Co., Ltd. was established in 2009 and is a company specializing in primary cell culture and screening, in vitro drug metabolism, and drug interaction evaluation products. We provide standard and standardized products for pharmaceutical companies, drug research institutes, disease control centers, new drug safety evaluation centers, and various scientific research institutions, and are committed to building a platform for the research and screening of primary cell biopharmaceuticals.
The company provides comprehensive services for cell culture, including primary cells, cell culture reagents, in vitro metabolic reagents, etc. At the same time, the company also provides multiple biopharmaceutical outsourcing services such as drug development and screening of primary cell drugs. Each research team is equipped with multiple experienced experts who can provide efficient and high-quality services for your scientific research. With its technological strength and rich experience in the field of primary cells, the company is focusing on creating a new generation of biopharmaceutical screening platform based on primary cells, which is used to identify and screen candidate drugs, detect drug toxicity, thereby saving new drug development time and costs, and improving the quality of new drugs.
Cell biology product expert - Qishi Biotechnology, your trusted partner!